Product Information
CAMRESE 0.15-0.03-0.01 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1248 per EA under NDC 00093313482. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 25, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093313482
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA021840FDA Approved
5/25/2006
TE Code
AB
On Market Since
7/28/2011
Price Statistics
The NADAC for CAMRESE 0.15-0.03-0.01 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 93.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1248 per EA |
|---|---|
| All-time high | $2.0901 (Nov 12, 2014) |
| All-time low | $0.1165 (Mar 18, 2026) |
| 52-week high | $0.1825 |
| 52-week low | $0.1165 |
| Median price | $0.6264 |
| Average price | $0.8992 |
| Largest weekly change | +45.4% (Nov 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levonorgestrel / Ethinyl Estradiol and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel / Ethinyl Estradiol and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAMRESE 0.15-0.03-0.01 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CAMRESE 0.15-0.03-0.01 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1248 per EA (NDC 00093313482), effective Sep 30, 2026.
How has the price of CAMRESE 0.15-0.03-0.01 MG TAB changed over time?
Over the history we have for it, the NADAC for CAMRESE 0.15-0.03-0.01 MG TAB has declined 93.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CAMRESE 0.15-0.03-0.01 MG TAB?
Since Nov 28, 2013, the NADAC for CAMRESE 0.15-0.03-0.01 MG TAB has ranged from a low of $0.1165 (Mar 18, 2026) to a high of $2.0901 (Nov 12, 2014), with a median of $0.6264 per EA.
Are there cheaper alternatives to CAMRESE 0.15-0.03-0.01 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of CAMRESE 0.15-0.03-0.01 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CAMRESE 0.15-0.03-0.01 MG TAB?
CAMRESE 0.15-0.03-0.01 MG TAB (NDC 00093313482) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.